Sativex

GW Pharma growing area for CBD Epidiolex

Pharma

Jazz must hash new plan for cannabis drug after MS trial failure

Jazz said that its nabiximols oromucosal spray has flunked a phase 3 trial, coming up short in helping multiple sclerosis patients with spasticity.

Kevin Dunleavy Jun 28, 2022 10:35am

Cannabis

GW Pharma wins historic FDA nod for cannabis-based drug

Jun 25, 2018 5:25pm